Matthew P Goetz

35PUBLICATIONS

296CO-AUTHORS

Proteins and peptidesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (35)

Sort by Publication Date:

|May 21, 2026

Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase Cβ.

|Oct 24, 2025

CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.

Andrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel

|Oct 02, 2025

Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Thomas E Mürdter, Werner Schroth, Matthew P Goetz

|Aug 28, 2025

Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer".

Matthew P Goetz, Grace M Choong, Tanya L Hoskin

|Apr 11, 2025

Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast Cancer.

Grace M Choong, Tanya L Hoskin, Judy C Boughey

|Feb 19, 2025

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.

Reiner Hoppe, Stefan Winter, Wing-Yee Lo

Pageof 6

Frequent Collaborators

12 joint publications

James N Ingle

Judy C Boughey

Miguel Martin

Jason Sinnwell

Liewei Wang

Tufia Haddad

John R Hawse

Eric P Winer

Angela M DeMichele

Huanyao Gao

Frequent Collaborators

12 joint publications

James N Ingle

8 joint publications

Judy C Boughey

5 joint publications

Miguel Martin

4 joint publications

Jason Sinnwell